NTII — Neurobiological Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Neurobiological Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	R2005 June 30th	2006 June 30th	C2007 June 30th	2008 June 30th	2009 June 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8.51	15.2	8.96	30	24
Net Total Accounts Receivable
Net Total Receivables	0.053	5.6	0.43	0.599	0.184
Prepaid Expenses
Total Current Assets	9.11	21.7	10.2	30.9	24.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.597	0.752	0.587	0.393	0.07
Long Term Investments
Other Long Term Assets
Total Assets	9.82	22.5	10.9	43.2	24.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.82	9.61	14.2	9.04	1.11
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.82	33.9	33	22.9	1.11
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6	-11.4	-22.1	20.3	23.5
Total Liabilities & Shareholders' Equity	9.82	22.5	10.9	43.2	24.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding